These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35718676)

  • 1. Survival benefit of adjuvant chemotherapy following neoadjuvant therapy and oesophagectomy in oesophageal adenocarcinoma.
    Kamarajah SK; Markar SR; Phillips AW; Kunene V; Fackrell D; Salti GI; Dahdaleh FS; Griffiths EA
    Eur J Surg Oncol; 2022 Sep; 48(9):1980-1987. PubMed ID: 35718676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival Benefit of Adjuvant Chemotherapy After Pancreatoduodenectomy for Ampullary Adenocarcinoma: a Propensity-Matched National Cancer Database (NCDB) Analysis.
    Kamarajah SK; Bednar F; Cho CS; Nathan H
    J Gastrointest Surg; 2021 Jul; 25(7):1805-1814. PubMed ID: 33230687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant radiotherapy improves long-term survival after resection for gallbladder cancer A population-based cohort study.
    Kamarajah SK; Al-Rawashdeh W; White SA; Abu Hilal M; Salti GI; Dahdaleh FS
    Eur J Surg Oncol; 2022 Feb; 48(2):425-434. PubMed ID: 34518052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy for perihilar cholangiocarcinoma: A population-based comparative cohort study.
    Kamarajah SK; Al-Rawashdeh W; Parente A; Atherton P; Salti GI; Dahdaleh FS; Manas D; Hilal MA; White SA
    Eur J Surg Oncol; 2022 Jun; 48(6):1300-1308. PubMed ID: 34916085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population-Based Cohort Study.
    Kamarajah SK; White SA; Naffouje SA; Salti GI; Dahdaleh F
    Ann Surg Oncol; 2021 Oct; 28(11):6790-6802. PubMed ID: 33786676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant therapy following oesophagectomy for adenocarcinoma in patients with a positive resection margin.
    Bott RK; Beckmann K; Zylstra J; Wilkinson MJ; Knight WRC; Baker CR; Kelly M; Maisey N; Qureshi A; Sevitt T; Van Hemelrijck M; Smyth EC; Allum WH; Lagergren J; Gossage JA; Cunningham D; Davies AR;
    Br J Surg; 2020 Dec; 107(13):1801-1810. PubMed ID: 32990343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer.
    Burt BM; Groth SS; Sada YH; Farjah F; Cornwell L; Sugarbaker DJ; Massarweh NN
    Ann Surg; 2017 Aug; 266(2):297-304. PubMed ID: 27501170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis.
    Kamarajah SK; Sonnenday CJ; Cho CS; Frankel TL; Bednar F; Lawrence TS; Nathan H
    Ann Surg; 2021 Mar; 273(3):587-594. PubMed ID: 30817352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy versus chemoradiation in high-risk pancreatic adenocarcinoma: A propensity score-matched analysis.
    Raoof M; Blakely AM; Melstrom LG; Lee B; Warner SG; Chung V; Singh G; Chen YJ; Fong Y
    Cancer Med; 2019 Oct; 8(13):5881-5890. PubMed ID: 31414566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study.
    Pu N; Wu W; Liu S; Xie Y; Yin H; Chen Q; He T; Xu Z; Wang W; Yu J; Liu L; Lou W
    Int J Surg; 2023 Oct; 109(10):3137-3146. PubMed ID: 37418574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant Chemotherapy Improves Overall Survival of Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy Regardless of Pathologic Nodal Status.
    Kulaylat AS; Hollenbeak CS; Stewart DB
    Ann Surg Oncol; 2017 May; 24(5):1281-1288. PubMed ID: 27864695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
    Kamarajah SK; Bednar F; Cho CS; Nathan H
    Cancer; 2021 Apr; 127(8):1266-1274. PubMed ID: 33320344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant Chemotherapy for Intrahepatic, Perihilar, and Distal Cholangiocarcinoma: a National Population-Based Comparative Cohort Study.
    Parente A; Kamarajah SK; Baia M; Tirotta F; Manzia TM; Hilal MA; Pawlik TM; White SA; Dahdaleh FS
    J Gastrointest Surg; 2023 Apr; 27(4):741-749. PubMed ID: 36749556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of adjuvant chemotherapy after neoadjuvant chemotherapy or chemoradiotherapy plus esophagectomy in patients with esophageal cancer: a retrospective cohort study.
    He H; Zhang P; Li F; Liu D; Wu K
    J Gastrointest Oncol; 2022 Dec; 13(6):2736-2748. PubMed ID: 36636082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy is associated with improved survival after esophagectomy without induction therapy for node-positive adenocarcinoma.
    Speicher PJ; Englum BR; Ganapathi AM; Mulvihill MS; Hartwig MG; Onaitis MW; D'Amico TA; Berry MF
    J Thorac Oncol; 2015 Jan; 10(1):181-8. PubMed ID: 25490005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis.
    Hölscher AH; Bollschweiler E; Bogoevski D; Schmidt H; Semrau R; Izbicki JR
    Eur J Cancer; 2014 Nov; 50(17):2950-7. PubMed ID: 25307749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma.
    Groth SS; Burt BM; Farjah F; Smaglo BG; Sada YH; Sugarbaker DJ; Massarweh NN
    J Thorac Cardiovasc Surg; 2019 Apr; 157(4):1682-1693.e1. PubMed ID: 30711279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of Adjuvant Chemotherapy Use and Association With Survival in Adults 80 Years and Older With Pancreatic Adenocarcinoma.
    Mehtsun WT; McCleary NJ; Maduekwe UN; Wolpin BM; Schrag D; Wang J
    JAMA Oncol; 2022 Jan; 8(1):88-95. PubMed ID: 34854874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis.
    Deng A; Wang C; Cohen SJ; Winter JM; Posey J; Yeo C; Basu Mallick A
    Eur J Cancer; 2021 Apr; 147():17-28. PubMed ID: 33607382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing survival between neoadjuvant chemoradiotherapy followed by open or thoracoscopic oesophagectomy in patients with oesophageal squamous cell carcinoma.
    Chen HS; Lin CH; Wu SC; Wang BY
    Eur J Cardiothorac Surg; 2022 Jul; 62(2):. PubMed ID: 35303068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.